Tech Trail
-
DeepTech venture builder raises over $3m top-up funding
Cambridge Future Tech, a tech-first venture builder, reports the initial close of a funding round that raised over $3 million – marking a significant... Read More
-
Investors in Harness as Cambridge biotech takes funding to £17.6m
Biotech company Harness Therapeutics in Cambridge has raised an extra £4 million growth capital from existing investors to take its haul to £17.6m to... Read More
-
ImmuONE raises £2m for 3D human lung model to replace animal testing
Two scientists who have developed a 3D human lung model that can assess the safety of new drugs without the use of animal testing have raised £2... Read More
-
Amadeus Capital Partners backs $100m round for Photonic Inc
Cambridge VC company Amadeus Capital Partners has invested in a $100 million raise alongside Microsoft Corporation and others for Canadian company... Read More
-
Cambridge Angels leads $5m pre-seed round for US silicon startup
Cambridge Angels has led a $5 million pre-seed round in zeroRISC, a startup based in Boston Massachusetts. Business Weekly believes it to be the... Read More
-
Cambridge trio help boost pension fund investment in high-growth companies in £50bn play
Three VC investors with Cambridge operations – Amadeus Capital Partners, Cambridge Innovation Capital and IQ Capital – are among 20 of the UK’s... Read More
-
Immaterial cleans up with Series A cash to build manufacturing demo plant
University of Cambridge spin-out Immaterial Ltd has completed an undisclosed Series A funding round – just days after winning a major category of the... Read More
-
Kuano funding hits £2.8m with latest haul to fast-track design of nextgen medicines
Kuano, a Cambridge-based drug discovery company combining quantum mechanics with AI to design nextgen medicines, has closed a £1.8 million seed... Read More
-
Funding from US investor underpins global scale-up for Echion Technologies
A big-hitting US investor majoring in transformational technologies that accelerate global energy transition has pumped significant growth capital... Read More
-
M Ventures leads Lightcast Discovery’s $49m Series B raise
Life science tools business Lightcast Discovery – with bases in Cambridge UK and Boston US – has raised a $49 million Series B round. It is a... Read More
-
Mestag – signalling a new era in immunotherapy
Mestag is an immunotherapy company harnessing new insights into fibroblast-immune cell interactions to develop innovative treatments for cancer and... Read More
-
Revvity expanding the boundaries of human potential through science
Revvity, a visionary partner in developing technologies and solutions across disease pathways, is revolutionising the field of gene editing and... Read More
-
Fraud and financial crime fighter Featurespace continues growth trajectory in the US
Featurespace continues to maintain a leading position as a provider of enterprise fraud and financial crime prevention software on both sides of the... Read More
-
CellCentric wins $25m from Pfizer for cancer collaboration
Cambridge biotech game-changer CellCentric has secured a strategic investment of $25 million from global biopharma company Pfizer to support the... Read More
-
A Pragmatic approach to US expansion
When Scott White, founder of Pragmatic Semiconductor, visited the White House earlier this year it was to discuss the $52.7 billion CHIPS Act, which... Read More
-
Camena Bioscience raises $10m scale-up funding
Camena Bioscience, a synthetic biology company providing genes to the pharmaceutical and biotechnology industries, has closed a $10 million Series A... Read More
-
Robok takes scale-up funding to $4m
RoboK, a Cambridge startup applying AI-powered computer vision to logistics & industrial workplaces, has clinched a $2.1 million Series A... Read More
-
SMi Systems raises £6m seed funding in charge towards commercialisation
SMi Systems, a US business with Cambridgeshire offices and specialising in single molecule imaging and quantification technologies for biomedical... Read More
-
BIOS Health raises significant funding from Silicon Valley and elsewhere
Cambridge company BIOS Health, a pioneer in the development of AI-driven precision medicine for the nervous system, is set to scale fast after... Read More
-
New brand reflects Sphere Fluidics’ culture and ambitions
For more than a decade, Sphere Fluidics has honed its expertise in scientific and engineering research and development to create novel microfluidic... Read More